Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

Status Recruiting

Clinical Trial Summary

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of this disease in people with EGPA.

Clinical Trial Description

EGPA, also known as allergic granulomatosis angiitis, is a systemic vasculitis. EGPA is marked by three distinct symptoms: asthma; eosinophilia, evidenced by an excessive number of eosinophils in the blood and tissues; and vasculitis involving the skin, lungs, nerves, kidneys, and other organs. Nerve involvement may also occur in EGPA, causing pain, tingling, numbness, and muscle wasting in the hands and feet. Because EGPA patients may not show any visible signs of active disease, current methods of monitoring disease progression usually represent a period of extended inflammation and disease activity. Thus, patients may go untreated during a period of undetectable disease when damage might be preventable. This study will use novel scientific methods to identify new biomarkers that can be used to monitor disease activity in EGPA patients. These biomarkers may be used to help direct clinical care for EGPA patients and assist in future drug development. Study visits will occur every 6 months, or annually. Blood and urine collection will occur at every visit. A physical exam and medical and medication history will at every visit; also, participants will be asked to complete several questionnaires to assess disease activity, health status, and tobacco, alcohol, and drug use. ;

Study Design

Related Conditions & MeSH terms

Churg-Strauss Syndrome
Eosinophilic Granulomatosis With Polyangiitis
Granulomatosis with Polyangiitis
Systemic Vasculitis

Clinical Trial Details

NCT number	NCT00315380
Study type	Observational
Source	University of Pennsylvania
Contact
Status	Recruiting
Phase
Start date	April 2006
Completion date	December 2028

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01729624` - PRO Development for ANCA Associated Vasculitis	N/A
Completed	`NCT02190916` - Vasculitis Illness Perception (VIP) Study	N/A
Recruiting	`NCT02967068` - VCRC Tissue Repository
Completed	`NCT02190942` - VCRC Patient Contact Registry Patient-Reported Data Validation Study
Completed	`NCT00307593` - RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides	N/A
Completed	`NCT02190929` - Educational Needs of Patients With Systemic Vasculitis	N/A
Active, not recruiting	`NCT00006055` - Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases	N/A
Active, not recruiting	`NCT03557060` - NUCALA® Special Drug Use Investigation (EGPA, Long-term)
Terminated	`NCT00424749` - Rituxan in Churg Strauss Syndrome With Renal Involvement	Phase 2
Completed	`NCT00307671` - Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years	Phase 4
Active, not recruiting	`NCT00399399` - CHUSPAN SCS BP Treatment of Churg–Strauss Syndrome Without Poor-Prognosis Factors	Phase 4
Completed	`NCT02020889` - A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis	Phase 3
Completed	`NCT02176070` - Reproductive Health in Men and Women With Vasculitis	N/A
Completed	`NCT00266565` - Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome	Phase 1/Phase 2
Recruiting	`NCT06046222` - Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis	Phase 2
Recruiting	`NCT04316494` - Hydroxychloroquine in ANCA Vasculitis Evaluation	Phase 4
Active, not recruiting	`NCT04551989` - Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan
Recruiting	`NCT04671446` - Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma
Completed	`NCT03036670` - Eosinophilic Granulomatosis With Polyangiitis Cohort
Terminated	`NCT02728271` - Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome	Early Phase 1